1968 studies found for:    HIV [CONDITION] AND NIH [SPONSOR-COLLABORATORS-CLASS] NOT NIMH [ORGANIZATION-NAME]
Show Display Options
Rank Status Study
21 Completed A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss
Conditions: HIV Infections;   HIV Wasting Syndrome
Intervention: Drug: Nandrolone decanoate
22 Completed A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss
Conditions: HIV Infections;   HIV Wasting Syndrome
Interventions: Drug: Testosterone enanthate;   Drug: Megestrol acetate
23 Completed ALVAC-HIV vCP1452 Alone and Combined With MN rgp120
Conditions: HIV Infections;   HIV Seronegativity
Interventions: Biological: ALVAC(2)120(B,MN)GNP (vCP1452);   Biological: MN rgp120/HIV-1;   Biological: ALVAC(2)120(B,MN)GNP (vCP1452) placebo;   Biological: MN rgp120/HIV-1 placebo
24 Completed A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules
Conditions: HIV Infections;   HIV Seronegativity
Intervention: Biological: gp160 Vaccine (Immuno-AG)
25 Completed A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers
Conditions: HIV Infections;   HIV Seronegativity
Interventions: Biological: Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203);   Biological: Aluminum hydroxide;   Biological: MF59;   Biological: rgp120/HIV-1MN
26 Completed Screening Protocol for HIV Vaccine Studies
Conditions: HIV Seronegativity;   HIV Infections
Intervention:
27 Completed A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine
Conditions: HIV Infections;   HIV Seronegativity
Intervention: Biological: ALVAC-HIV MN120TMG (vCP205)
28 Completed Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults
Conditions: HIV Infections;   HIV Seronegativity
Intervention: Biological: ALVAC(2)120(B,MN)GNP (vCP1452)
29 Withdrawn Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
Conditions: HIV Infections;   Pregnancy;   HIV Seronegativity
Interventions: Biological: MF59;   Biological: rgp120/HIV-1 SF-2
30 Completed A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers
Conditions: HIV Infections;   HIV Seronegativity
Interventions: Biological: rgp120/HIV-1MN;   Biological: rgp120/HIV-1 SF-2;   Biological: Placebo version of rgp120/HIV-1MN;   Biological: Placebo version of rgp120/HIV-1SF2
31 Completed Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)
Conditions: HIV Infections;   Pregnancy;   HIV Seronegativity
Intervention: Biological: gp160 Vaccine (MicroGeneSys)
32 Completed Carotid Artery Thickness in HIV Infected and Uninfected Adults
Conditions: HIV Infections;   HIV Seronegativity;   Atherosclerosis
Intervention:
33 Completed Safety and Effectiveness of the Vaccine ALVAC-HIV vCP205 in HIV-Negative Adult Volunteers in Uganda
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV MN120TMG (vCP205);   Biological: ALVAC-RG Rabies Glycoprotein (vCP65)
34 Completed Family-based HIV Prevention for Adolescent Girls
Condition: HIV Infections
Intervention: Behavioral: Family-Based Risk Reduction Intervention
35 Completed Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma
Conditions: HIV Seropositivity;   Kaposi's Sarcoma;   HIV Infections
Intervention:
36 Completed Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Nelfinavir mesylate;   Drug: Nevirapine;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine
37 Completed Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women
Conditions: HIV Infections;   Pregnancy
Intervention:
38 Completed A Study of Immune System Activity in Healthy Adults
Conditions: HIV Infections;   HIV Seronegativity
Intervention:
39 Completed A Study to Test the Safety of Three Experimental HIV Vaccines
Conditions: HIV Infections;   HIV Seronegativity
Interventions: Biological: HIV p24/MF59 Vaccine;   Biological: ALVAC-HIV MN120TMG (vCP205);   Biological: ALVAC-RG Rabies Glycoprotein (vCP65);   Biological: rgp120/HIV-1 SF-2
40 Completed Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa
Conditions: HIV Infections;   HIV Seronegativity
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years